Not really a distraction. If they publish some great results in a medical journal they need to enable excited investors to buy shares. They have just doubled at least investors who now have access to buy from the same low number of shares on issue. With 200 million shares now accessible from both asx and German markets this could move very fast as we recently saw from 30c to $1.60.
Bear in mind that movexwas with ASX action only. Imagine if good results get German investors excited as well. And all with no additional shares or dilution.
Ann: Recce Applies for Dual Listing on Frankfurt Stock Exchange, page-43
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.025(5.62%) |
Mkt cap ! $121.4M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 41.5¢ | $45.92K | 107.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 120 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 15.59pm 28/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |